Generalized Pustular Psoriasis
Last Posted: Nov 13, 2020
- Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis.
Liu Zhi-Jie, et al. Medicine 2020 11 (45) e23068
- Tumor necrosis factor -238A is associated with pediatric-onset generalized pustular psoriasis in Han patients in Eastern China.
Zhao Lishi, et al. The Journal of dermatology 2019 8
- Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China: A case-control study.
Li Zhongtao, et al. Medicine 2018 8 (31) e11741
- Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
Zhu Teng, et al. European journal of dermatology : EJD 2018 4
- The genetic basis for most patients with pustular skin disease remains elusive.
Mössner R, et al. The British journal of dermatology 2017 8
- Mutation analysis of IL36RN gene in Japanese patients with palmoplantar pustulosis.
Takahashi Toshifumi, et al. The Journal of dermatology 2016 8
- Tumor Necrosis Factor-alpha Induced Protein 3 Interacting Protein 1 Gene Polymorphisms and Pustular Psoriasis in Chinese Han Population.
Han Jian-Wen, et al. Chinese medical journal 0 0 (13) 1519-1524
- Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
Arakawa Akiko, et al. JAMA dermatology 2016 4
- Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients.
Wang Ting-Shun, et al. Archives of dermatological research 2015 11
- HLA-C and TNF gene polymorphisms are associated with psoriasis in Brazilian patients.
Cardili Renata N, et al. International journal of dermatology 2015 10
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.